2型糖尿病的强化胰岛素治疗

　　2 Watkins P.J，Drury P.L，Howell SL.Diabetes and Its Management.5th  Edition.Oxford:Black well Science，1996，38:1083.

    3 刘国良.2型糖尿病胰岛素治疗的指征.中国实用内科杂志，2000，20（12）:87.

    4 王坚.糖尿病胰岛素治疗方案的选择与临床应用.临床荟萃，1999，14（11）:494.

    5 Alberti.KGMM，De Fronzo.RA，Keen.H，et al.International Text book of Diabetes Mellitus.Chichester:John Wiley&Sons，1992，831-834.

　6 Bardin CW.Current Therapy in Endocrinology and Metabolism.6th Edition.StLouis:Mosby，1997，413-438.

    7 The Diabetes Control and Complications Tial Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med，1993，329:9776.

    8 Small M，Macr Rury S，Boal A，et al.Comparison of conventional twice daily subcutaneous insulin administration and amultiple injection regi-men in insulin-dependent diabetes mellitus.Diabetes Res，1988，8:857.

    9 Tunbridge FKE，Owens A，Home OD，et al.Double blind crossover trail of isophane（NPH）and Lente based insulin regimens.Diabetes Care，1989，12:1158.

    10 Francis AJ，Hanning I，Alberti KGMM.Human ultralente:a comparison with porcinelente insulin asa twice daily insulin in insulin-dependent diabetes patients with fasting hyperglycaemia.Diabetes Res，1986，3:2639.

    11 Davis RR，McEwan J，Moreland TA.Improvement in morning hypergly-caemia with basal human ultratard and prandial human Act rapid in-sulin;acomparison of multiple injection regimens.Diabet Med，1988，5:671-710.

    12 Chantelau E，Spraul M，Muhlhauser I，et al.Long term safety，efficacy and side-effects of continuous subcutaneous insulin in fusion treat-ment for type1（insulin-dependent）diabetes mellitus:aonecentre ex-perience.Diabetologia，1989，32（7）:421-426.

    13 Diabetes Control and Complications Trial Research Group.Implementa-tion of treatment protocols in the Diabetes Control and Complications Trial.Diabetes Care，1995，13（4）:427-433.

    14 Udelsman R，Chen H，Loman K，et al.Implanted programmable insulin pumps:One hundred fifty three patient years of surgical experience.Surgery，1997，122（6）:1005-1011.

    15 Schnell O，Eisfelder B，Standl E，et al.High dose intravenous insulin in fusion versus intensive in sulin treatment in newly diagnosed IDDM.Diabetes，1997，46:1607-1615.

    16 Koivisto VA.Insulin therapy in type diabetes.Diabetes Care，1993，16（Suppl.3）:29-39.

    17 Romano G，Patti L，Innelli F，et al.Insulin and sulfonylurea the rapy in NIDD M patients.Diabetes，1997，46（10）:1601-1606.

    18 Wei M，Mitchell BD，Haffner SM，et al.Effects of cigarette smoking，diabetes，high cholesterol and hypertension on all cause mortality and cardiovascular disease mortality inMexican Americans.Am J Epidemi-ol，1996，144（11）:1058-1065.

    19 MuggeoM，Verlato G，Bonora E，et al.Ling-term instability of fasting plasma glucose predicts mortality in elderly NIDD M patients:the Verona Diabetes Study.Diabetologia，1995，38（6）:672-679.

    20 UK Prospective Diabetes Study（UKPDS）Group.Intensive blood glu-cose control with sulphonylureasor insulin compared with conventional treatment and risk of complications in patients with type2diabetes（UKPDS）.Lancet，1998，352（9131）:837-853.

    21 UK Prospective Diabetes Study（UKPDS）Group.Effect of intensive blood glucose control with met forming on complications in over weight patients with type2diabetes（UKPDS）.Lancet，1998，352（9131）:854 -865.

    22 Saudek CD，Duckworth WC，Giobbie Hurder A，et al.Implantable in-sulin pump vsmultiple dose insulin for noninsulin-dependent diabetes-mellitus.JAMA，1996，276:1322-1328.

    23 Point Study Group.Multicentre trial of a programmable implantable in-sulin pump in type1diabetes.Int J Artif Organs，1995，18（6）:322-325.